LAURA MILLER: Open Payments
NPI 1336924216 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 88 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $545 · 2025 $1,640
Food & beverage: $1,640
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $345 |
| GENZYME CORPORATION | 8 | $290 |
| QOL Medical, LLC | 7 | $204 |
| Janssen Biotech, Inc. | 22 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $120 |
| Madrigal Pharmaceuticals | 5 | $99 |
| Ardelyx, Inc. | 3 | $65 |
| Gilead Sciences, Inc. | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
Products named: DUPIXENT, RINVOQ, Sucraid, TREMFYA, ENTYVIO, REZDIFFRA, CREON, IBSRELA.
Industry payments across SC — which companies pay providers there.
